文献速递糖尿病肥胖与代谢综合征

印度15个邦糖尿病与糖尿病前期的患病率:ICMR-INDIAB基于人群的横断面研究结果

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-06-07

该研究采用分层多阶段设计,在印度14个邦和1个联邦属地抽样57117名20岁及以上成年人,按WHO标准行毛细血管口服葡萄糖耐量试验。15个邦总体糖尿病患病率为7.3%(95%CI 7.0-7.5),糖尿病前期为10.3%(10.0-10.6);糖尿病患病率从比哈尔邦的4.3%到旁遮普邦的10.0%不等,城市高于农村, mainland邦高于东北部。

要点

  • 15个邦总体糖尿病患病率7.3%,糖尿病前期10.3%。
  • 城市糖尿病患病率11.2%高于农村5.2%(p<0.0001)。
  • 3938例糖尿病患者中1862例(47.3%)既往未诊断。

核心结论

  • 印度各邦糖尿病患病率差异很大,结果提示流行病学转变,在经济较发达邦的城市低社会经济地位人群中糖尿病患病率更高。
  • 糖尿病向社会经济弱势群体蔓延令人高度关注,需要紧急预防措施。

研究设计与样本

  • 印度医学研究理事会-INDIAB研究采用分层多阶段设计,获取社区样本57117名20岁及以上个体,代表印度28个邦中的14个邦(8个大陆邦和6个东北部邦)和1个联邦属地。
  • 分阶段抽样:第一阶段包括泰米尔纳德邦、昌迪加尔、贾坎德邦和马哈拉施特拉邦,采样时间为2008年11月17日至2010年4月16日;第二阶段包括安得拉邦、比哈尔邦、古吉拉特邦、卡纳塔克邦和旁遮普邦,采样时间为2012年9月24日至2013年7月26日;东北部阶段包括阿萨姆邦、米佐拉姆邦、阿鲁纳恰尔邦、特里普拉邦、曼尼普尔邦和梅加拉亚邦,采样时间为2012年1月5日至2015年7月3日。
  • 采用毛细血管口服葡萄糖耐量试验按WHO标准诊断糖尿病和糖尿病前期。
  • 方法无法区分1型和2型糖尿病。

主要发现

  • 所有15个邦糖尿病总体患病率为7.3%(95%CI 7.0-7.5),从比哈尔邦的4.3%(95%CI 3.7-5.0)到旁遮普邦的10.0%(95%CI 8.7-11.2)不等。
  • 城市糖尿病患病率为11.2%(95%CI 10.6-11.8),高于农村的5.2%(95%CI 4.9-5.4),p<0.0001;大陆邦为8.3%(95%CI 7.9-8.7),高于东北部的5.9%(95%CI 5.5-6.2),p<0.0001。
  • 3938名被识别为糖尿病的个体中,1862名(47.3%)既往未诊断。
  • 人均GDP较高的邦似乎糖尿病患病率更高,例如昌迪加尔人均GDP最高为3433美元,患病率最高为13.6%(95%CI 12.8-15.2)。
  • 所有邦农村地区高社会经济地位个体糖尿病更常见,而昌迪加尔、马哈拉施特拉邦和泰米尔纳德邦等较富裕邦的城市地区低社会经济地位人群糖尿病患病率更高。

关键数值与推荐

  • 糖尿病诊断采用毛细血管口服葡萄糖耐量试验,依据WHO标准。
  • 糖尿病前期包括空腹血糖受损和糖耐量受损,依据WHO标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 方法无法区分1型和2型糖尿病。
  • 作者结论指出糖尿病向社会经济弱势群体蔓延令人高度关注,需要紧急预防措施,并认为结果提示流行病学转变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have not adequately captured the heterogeneous nature of the diabetes epidemic in India. The aim of the ongoing national Indian Council of Medical Research-INdia DIABetes study is to estimate the national prevalence of diabetes and prediabetes in India by estimating the prevalence by state. METHODS: We used a stratified multistage design to obtain a community-based sample of 57 117 individuals aged 20 years or older. The sample population represented 14 of India's 28 states (eight from the mainland and six from the northeast of the country) and one union territory. States were sampled in a phased manner: phase I included Tamil Nadu, Chandigarh, Jharkhand, and Maharashtra, sampled between Nov 17, 2008, and April 16, 2010; phase II included Andhra Pradesh, Bihar, Gujarat, Karnataka, and Punjab, sampled between Sept 24, 2012, and July 26, 2013; and the northeastern phase included Assam, Mizoram, Arunachal Pradesh, Tripura, Manipur, and Meghalaya, with sampling done between Jan 5, 2012, and July 3, 2015. Capillary oral glucose tolerance tests were used to diagnose diabetes and prediabetes in accordance with WHO criteria. Our methods did not allow us to differentiate between type 1 and type 2 diabetes. The prevalence of diabetes in different states was assessed in relation to socioeconomic status (SES) of individuals and the per-capita gross domestic product (GDP) of each state. We used multiple logistic regression analysis to examine the association of various factors with the prevalence of diabetes and prediabetes. FINDINGS: The overall prevalence of diabetes in all 15 states of India was 7·3% (95% CI 7·0-7·5). The prevalence of diabetes varied from 4·3% in Bihar (95% CI 3·7-5·0) to 10·0% (8·7-11·2) in Punjab and was higher in urban areas (11·2%, 10·6-11·8) than in rural areas (5·2%, 4·9-5·4; p<0·0001) and higher in mainland states (8·3%, 7·9-8·7) than in the northeast (5·9%, 5·5-6·2; p<0·0001). Overall, 1862 (47·3%) of 3938 individuals identified as having diabetes had not been diagnosed previously. States with higher per-capita GDP seemed to have a higher prevalence of diabetes (eg, Chandigarh, which had the highest GDP of US$ 3433, had the highest prevalence of 13·6%, 12.8-15·2). In rural areas of all states, diabetes was more prevalent in individuals of higher SES. However, in urban areas of some of the more affluent states (Chandigarh, Maharashtra, and Tamil Nadu), diabetes prevalence was higher in people with lower SES. The overall prevalence of prediabetes in all 15 states was 10·3% (10·0-10·6). The prevalence of prediabetes varied from 6·0% (5·1-6·8) in Mizoram to 14·7% (13·6-15·9) in Tripura, and the prevalence of impaired fasting glucose was generally higher than the prevalence of impaired glucose tolerance. Age, male sex, obesity, hypertension, and family history of diabetes were independent risk factors for diabetes in both urban and rural areas. INTERPRETATION: There are large differences in diabetes prevalence between states in India. Our results show evidence of an epidemiological transition, with a higher prevalence of diabetes in low SES groups in the urban areas of the more economically developed states. The spread of diabetes to economically disadvantaged sections of society is a matter of great concern, warranting urgent preventive measures. FUNDING: Indian Council of Medical Research and Department of Health Research, Ministry of Health and Family Welfare, Government of India.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017. PMID: 28601585. doi:10.1016/S2213-8587(17)30174-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。